BLQ considerations [Bioanalytics]

posted by Loky do – Egypt, 2022-03-28 14:16 (816 d 04:45 ago) – Posting: # 22873
Views: 2,301


Regarding BLQ samples in the middle of plasma concentration curves, which remain BLQ after reanalysis, what is the best practice for those samples in calculations? To be considered as (missed or Non-reported samples or blank)? Or to keep it as it is <LLOQ?

Thanks in advance

Edit: Merged with a later (now deleted) post. You can edit your posts for 24 hours. [Helmut]

Complete thread:

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,665 registered users;
33 visitors (0 registered, 33 guests [including 6 identified bots]).
Forum time: 19:02 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz